Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI Worldwide, MilanCPhI Worldwide, Milan
Not Confirmed
Not Confirmed
08-10 October, 2024
Boulder Peptide 2024Boulder Peptide 2024
Not Confirmed
Not Confirmed
16-19 September, 2024
Not Confirmed
Not Confirmed
17-19 September, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI Worldwide, MilanCPhI Worldwide, Milan
Industry Trade Show
Not Confirmed
08-10 October, 2024
Boulder Peptide 2024Boulder Peptide 2024
Industry Trade Show
Not Confirmed
16-19 September, 2024
Industry Trade Show
Not Confirmed
17-19 September, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/we-re-unlocking-life-changing-potential-in-complex-molecules-without-sacrificing-time-to-market
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/bms-bayer-takeda-pfizer-downsize-to-combat-cost-pressures-meet-restructuring-plans
29 Aug 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/08/29/2937846/0/en/Anaptys-Announces-Participation-in-September-Investor-Conferences.html
14 Aug 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/08/14/2929856/0/en/Anaptys-Announces-Pricing-of-100-Million-Underwritten-Registered-Direct-Offering.html
05 Aug 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/08/05/2924649/0/en/Anaptys-Announces-Second-Quarter-2024-Financial-Results-and-Provides-Business-Update.html
10 May 2024
// ENDPTS
https://endpts.com/iteos-to-raise-120m-xbrane-and-stada-to-out-license-lucentis-biosimilar/
09 May 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/05/09/2879226/0/en/Anaptys-Announces-First-Quarter-2024-Financial-Results-and-Provides-Business-Update.html
09 May 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/05/09/2879216/0/en/Anaptys-Announces-Positive-Top-Line-GEMINI-2-Phase-3-Clinical-Trial-Results-of-Imsidolimab-IL-36R-in-Generalized-Pustular-Psoriasis-GPP.html
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?